Predicting relapses in patients with autoimmune vascular disease

Patients with an autoimmune disorder called antineutrophil cytoplasmic antibody-associated vasculitis produce antibodies that damage blood vessels in the body. In some cases, patients' antibodies target a protein called myeloperoxidase. New research published in Arthritis & Rheumatology indicates that for patients in remission, reappearance of antibodies against myeloperoxidase is a sign that patients will experience a relapse of their disease.

The findings suggest that patients should undergo routine monitoring of against myeloperoxidase.

"Our results could be helpful in daily clinical practice related to antineutrophil cytoplasmic antibody-associated vasculitis," said co-author Dr. Ken-Ei Sada, of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, in Japan.


Explore further

Blood test helps predict relapse in patients with autoimmune disease affecting the kidneys

More information: Arthritis & Rheumatology, DOI: 10.1002/art.40538
Provided by Wiley
Citation: Predicting relapses in patients with autoimmune vascular disease (2018, May 23) retrieved 15 October 2019 from https://medicalxpress.com/news/2018-05-relapses-patients-autoimmune-vascular-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more